TURBO-CHARGE YOUR REGULATORY COMPLIANCE: WHY A SINGLE SYSTEM APPROACH IS BEST
August 5, 2013 | Pharma Compliance Monitor
Starting August 1, 2013 manufacturers of bio-pharmaceuticals and medical devices are required to begin collecting and tracking payment, transfer and ownership information when the Physician Payments Sunshine Act (PPSA) goes into effect. The purpose of PPSA is to reduce the potential for conﬂicts of interest that US-based health care providers (HCPs) or teaching hospitals could face as a result of their relationships with manufacturers…
Appian provides a leading low-code software development platform that enables organizations to rapidly develop powerful and unique applications. The applications created on Appian’s platform help companies drive digital transformation and competitive differentiation. For more information, visit www.appian.com.